Class Action Announcement (MGNX): A Securities Fraud Class Action Lawsuit Was Filed Against MacroGenics, Inc.Accesswire • 08/03/24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the FirmGlobeNewsWire • 08/03/24
MacroGenics, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the MGNX Class ActionBusiness Wire • 08/02/24
MGNX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. - Contact Kessler Topaz Meltzer & Check, LLPPRNewsWire • 08/02/24
MACROGENICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNXAccesswire • 08/02/24
Shareholders that lost money on MacroGenics, Inc. (MGNX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 08/01/24
MacroGenics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNXAccesswire • 08/01/24
Class Action Announcement for MacroGenics, Inc. (MGNX): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against MacroGenics, Inc.GlobeNewsWire • 08/01/24
MACROGENICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNXGlobeNewsWire • 08/01/24
NASDAQ:MGNX: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against MacroGenics, Inc.Business Wire • 07/31/24
After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer TrialBenzinga • 07/31/24
Investors who Lost Money on MacroGenics, Inc.(MGNX) Should Contact Levi & Korsinsky About Pending Class Action - MGNXAccesswire • 07/31/24
MacroGenics (MGNX) Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo - Hagens BermanAccesswire • 07/31/24
MGNX INVESTOR NOTICE: MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAccesswire • 07/31/24
The Schall Law Firm Is Investigating MacroGenics Inc And Encourages Its Shareholders To Reach Out To ThemAccesswire • 07/31/24
Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)GlobeNewsWire • 07/31/24
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 07/31/24
Investors in MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights – MGNXAccesswire • 07/31/24
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNXGlobeNewsWire • 07/30/24
MACROGENICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNXBusiness Wire • 07/30/24
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with IncyteGlobeNewsWire • 07/30/24
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc. (MGNX) InvestorsBusiness Wire • 07/30/24
Contact The Gross Law Firm by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX)GlobeNewsWire • 07/30/24
